The EPO granted patent EP4003228A1 to Edwards Lifesciences for a medical implant delivery system. The patent covers specific technical configurations for catheter-based implant delivery mechanisms, with IPC classifications indicating applications in cardiac valve replacement and related therapeutic implants. The filing date references February 2021.

Medical device manufacturers operating in the European market should conduct freedom-to-operate analyses before developing or marketing similar delivery catheter systems. Competitors risk infringement liability for any delivery systems falling within the patent's scope of protection, which extends across all designated contracting states for up to 20 years from the original filing date.